Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Powerus Awarded U.S. Air Force IDIQ Contract Up to $90 Million for Aerial Denial
-
Freedom Metals Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing August 4, 2026
-
Amogy and 2G Energy Successfully Demonstrate Integrated Ammonia-to-Power Generation with Natural Gas Multi-Fuel Capability
-
Aspida Life and Market Synergy Group Launch T. Rowe Price U.S. Equity 15 Index in Synergy Choice™ FIA Suite
-
Sweed Launches AI-Powered Smart Surveys With Google Review Capabilities for Cannabis Dispensaries
-
The best-selling Enduro motorcycle in the world is now electric, Stark is EBIT-Positive as First-Half-Year Revenues grow 46% to €86 Million
-
ASML reports transactions under its current share buyback program
-
Transaction in Own Shares
-
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.09 Per Share for August 2026
-
Nexera Enters into Letter of Intent for Exclusive Distribution Rights to Darknet Intelligence Platform for Data Centers
-
Helus Pharma Appoints Michael Halstead as Chief Executive Officer
-
Tyson Foods Third Quarter 2026 Financial Results Available on the Company’s Investor Relations Website
-
Curium Announces Definitive Agreement to Merge with Lantheus
-
Hydrofarm Completes Sale of Aurora Peat Products and Launches Project Agility to Scale Its Logistics Services Platform
-
SOLOWIN HOLDINGS’ (NASDAQ: AXG) Subsidiary AX Coin Bahrain Receives Sharia Certification for AXBHD Stablecoin
-
Zevra Therapeutics Announces Publication of Four-Year Real-World Data from U.S. Early Access Program Evaluating MIPLYFFA® (arimoclomol) in Niemann-Pick Disease Type C (NPC)
-
HUB Security Regains Full Compliance with Nasdaq Listing Requirements
-
Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom
-
Crescent Biopharma Announces Grants of Inducement Awards
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results
-
Navigator Gas Announces Signing of $121.8 Million Financing for Two Newbuild Ammonia Carriers in Navigator Amon Joint Venture
-
Bombardier to Showcase its Exquisite Challenger 3500 at LABACE 2026 as Part of Extensive Multi-City Latin American Tour
-
BridgeBio to Report Second Quarter 2026 Financial Results and Commercial Updates on August 10, 2026 at 4:30 pm ET
-
BingX Appoints Kevin Lee as Chief Strategy Officer to Accelerate its Multi-Asset, User-Centric Vision
-
Man Group PLC : Form 8.3 - Senior plc
-
Luna PR Named "Most Innovative Emerging Tech PR Agency 2026" by Acquisition International
-
Luna PR Named "Most Innovative Emerging Tech PR Agency 2026" by Acquisition International
-
Man Group PLC : Form 8.3 - JTC Plc
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 31 07 2026] - (CGWL)
-
Man Group PLC : Form 8.3 - Gamma Communications
-
Toobit Offers 100% Loss Protection for New Copy Traders
-
Wine and Champagne Gifts Launches Same-Day Wine and Champagne Delivery in Los Angeles, CA
-
Total Voting Rights and Capital
-
Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors
-
OwlTing Group (NASDAQ: OWLS) Reports OwlPay Harbor July Payment Volume Increased 107.6% Month Over Month
-
Veritasium Goes Behind the Scenes at Kraig Biocraft Laboratories to Explore the Future of Commercial Spider Silk
-
Avista Corp. Reports Q2 2026 Financial Results, Confirms 2026 Utility Earnings Guidance
-
Transactions in connection with share buyback programme
-
X-energy, SGL Carbon Announce Capacity Expansion for Nuclear-Grade Graphite
-
Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results
-
Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S
-
Opus Genetics Completes Patient Enrollment in Registrational Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease
-
TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance
-
Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights
-
Lantronix CEO and CFO to Participate in Canaccord Genuity and Needham Conferences
-
Aurora Mobile's GPTBots.ai Launches LoopAgent: Production-Grade Execution That Runs Complex Tasks End-to-End
-
OutSolve Earns Two-Star Certification from The DaVinci Awards®
-
Robinson R88 Makes South American Debut at Labace 2026; Rugged Multi-Mission Helicopter Set to Disrupt the Latin American Market
-
Aurora Mobile's GPTBots.ai Launches LoopAgent: Production-Grade Execution That Runs Complex Tasks End-to-End
